Corvus Pharmaceuticals Inc. (CRVS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Corvus Pharmaceuticals In...

    NASDAQ: CRVS · Real-Time Price · USD
    7.19
    0.15 (2.13%)
    At close: Oct 03, 2025, 3:59 PM
    6.90
    -4.03%
    After-hours: Oct 03, 2025, 05:34 PM EDT

    Corvus Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 8.74M 12.62M 13.16M 63.46M
    Short-Term Investments
    		 43.22M 14.53M 29.14M 5.99M
    Long-Term Investments
    		 12.54M 16.12M 21.88M 34.27M
    Other Long-Term Assets
    		 632K 89K 1.84M 2.55M
    Receivables
    		 216K 63K 633K 539K
    Inventory
    		 n/a n/a -735K -667K
    Other Current Assets
    		 548K 220K 837K 795K
    Total Current Assets
    		 54.41M 27.96M 43.66M 71.31M
    Property-Plant & Equipment
    		 1.33M 1.39M 2.22M 3.19M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 14.5M 17.6M 25.94M 40M
    Total Assets
    		 68.91M 45.55M 68.24M 109.45M
    Account Payables
    		 2.58M 1.52M 1.98M 1.56M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 185K 1.37M 1.23M 1.05M
    Other Current Liabilities
    		 29.83M 1.91M 43K 921K
    Total Current Liabilities
    		 35.4M 6.87M 10.75M 9.69M
    Long-Term Debt
    		 n/a n/a 1.37M 2.6M
    Other Long-Term Liabilities
    		 n/a n/a -1.37M -2.6M
    Total Long-Term Liabilities
    		 937K n/a 1.37M 2.6M
    Total Liabilities
    		 36.34M 6.87M 12.13M 12.29M
    Total Debt
    		 1.12M 1.37M 2.6M 3.65M
    Book Value
    		 32.57M 38.68M 56.12M 97.16M
    Book Value Per Share
    		 0.53 0.81 1.21 2.32
    Common Stock
    		 7K 5K 5K 5K
    Retained Earnings
    		 -397.01M -334.72M -307.69M -266.38M
    Comprehensive Income
    		 -1.29M -967K -563K 1.87M
    Shareholders Equity
    		 32.57M 38.68M 56.12M 97.16M
    Total Investments
    		 55.76M 30.65M 51.02M 40.26M

    Add to Watchlist